News | April 16, 2024
Moderna pauses plan to build mRNA manufacturing facility in Kenya
The demand in Africa for COVID-19 vaccines has declined
The demand in Africa for COVID-19 vaccines has declined
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
Move strengthens footprint in Western India and expands multi-specialty care network
The initial consideration for the transaction is US$ 12 million
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
Subscribe To Our Newsletter & Stay Updated
